International Journal of Pharma and Bio Sciences
ijpbs.net
editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com
10.22376/ijpbs.2019.10.1.p1-12
Volume 11 Issue 1
2020 (January-March)
Assessment of the drug utilization pattern among chronic kidney disease patients with comorbid conditions
The aim of this study was to analyze the drug utilization pattern for different comorbid conditions among chronic kidney disease patients. A total of 176 patients were included in this study based on the inclusion and exclusion criteria. A specially designed proforma was used to collect demographic, clinical, and medication details. Among the 176 patients, 103 (58.52%) were females and 73 (41.48%) were males. The mean (±SD) age of total study population was 52±19.9 years and the prevalence of Chronic Kidney Disease (CKD) increased with ageing in both males and females. Prevalence of CKD was found to be higher for stage 3.Out of 176 patients, 24 (13.64%) male and 41 (23.30%) female patients had stage 3 CKD. Type 2 diabetes mellitus was found to be highly prevalent comorbid condition, followed by hypertension, anaemia and coronary artery disease. Insulin was the most common anti-diabetic drug prescribed (32.7%), calcium channel blockers were the most common antihypertensive drugs prescribed (48.8%), iron and vitamin supplements were the most commonly prescribed haematinics (68.1%) and the most commonly prescribed drug for coronary artery disease was found to be statins (38.9%). Type 2 diabetes mellitus was found to be highly prevalent co-morbid condition in CKD. To improve the disease management strategy and quality of life, time to time studies are required in drug utilization pattern.
M. RANGA PRIYA AND BINI K.P
Chronic kidney disease, Diabetes mellitus, Hypertension, Anaemia, Coronary artery disease.
1-7